Black Diamond Therapeutics Inc.

BDTX | NASDAQ

$1.94

-$0.01 (-0.51%)

Sep 22, 2026, 12:08 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
PE Ratio	6.23	-1.69	-1.49	-0.71	-1.54	-15.71
PEG Ratio	-0.05	0.05	0.06	0.03	-0.02	-0.20
PS Ratio	1.97	n/a	n/a	n/a	n/a	n/a
PB Ratio	1.23	1.41	1.06	0.56	0.98	3.43
P/FCF Ratio	4.67	-1.89	-1.85	-0.76	-1.88	-20.17
P/OCF Ratio	4.67	-1.89	-1.85	-0.77	-1.93	-20.23
OCF/S Ratio	42.31	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.17	0.27	0.22	0.24	0.15	0.03
Quick Ratio	8.42	4.92	6.82	8.37	9.12	22.48
Current Ratio	8.42	4.92	6.82	8.37	9.12	22.48
Asset Turnover	0.49	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a	n/a	-69.57K
Return on Equity	19.93%	-83.66%	-70.62%	-78.80%	-64.11%	-21.85%
Return on Assets	15.64%	-56.81%	-51.99%	-58.35%	-50.71%	-20.40%
Return on Invested Capital	15.17%	-74.69%	-60.87%	-64.54%	-56.55%	-21.98%
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	99.54%	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	31.95%	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	31.95%	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	28.39%	n/a	n/a	n/a	n/a	n/a
FCF Margin	42.31%	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	32.42%	n/a	n/a	n/a	n/a	n/a